Biomarkers for acute and chronic graft-versus-host disease in regulatory T cells

Transplant Immunology

Volumn 27, Issue 4, 2012, Pages 179-183

  Ukena, Sya N ^a   Geffers, Robert ^b   Buchholz, Stefanie ^a   Stadler, Michael ^a   Franzke, Anke ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Biomarker; GvHD; Regulatory T cells; Stem cell transplantation

Indexed keywords

ANKYRIN; BIOLOGICAL MARKER; CALGRANULIN A; CD30 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CYCLIN A2; CYCLIN B1; CYCLIN E; CYCLIN E2; CYCLOSPORIN A; ELAFIN; FAS ANTIGEN; FC RECEPTOR; HERMES ANTIGEN; IKAROS TRANSCRIPTION FACTOR; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 8; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE GAMMA; SCATTER FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOPTIVE TRANSFER; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; ENZYME ACTIVATION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; RISK FACTOR;

ACUTE DISEASE; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD44; ANTIGENS, CD95; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; CELL CYCLE PROTEINS; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LECTINS, C-TYPE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84869863428     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2012.07.003     Document Type: Article

References (27)

1. Glucksberg H., Storb R., Fefer A., Buckner C.D., Neiman P.E., Clift R.A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
2. Przepiorka D., Weisdorf D., Martin P., Klingemann H.G., Beatty P., Hows J., et al. Consensus conference on acute gvhd grading. Bone Marrow Transplant 1995, 15:825-828.
3. Kaiser T., Kamal H., Rank A., Kolb H.J., Holler E., Ganser A., et al. Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood 2004, 104:340-349.
4. Srinivasan R., Daniels J., Fusaro V., Lundqvist A., Killian J.K., Geho D., et al. Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis. Exp Hematol 2006, 34:796-801.
5. Weissinger E.M., Schiffer E., Hertenstein B., Ferrara J.L., Holler E., Stadler M., et al. Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood 2007, 109:5511-5519.
6. Chen Y.B., McDonough S., Hasserjian R., Chen H., Coughlin E., Illiano C., et al. Expression of CD30 in patients with acute graft-vs.-host disease. Blood 2012, 120:691-696.
7. Paczesny S., Krijanovski O.I., Braun T.M., Choi S.W., Clouthier S.G., Kuick R., et al. A biomarker panel for acute graft-versus-host disease. Blood 2009, 113:273-278.
8. Ferrara J.L., Harris A.C., Greenson J.K., Braun T.M., Holler E., Teshima T., et al. Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood 2011, 118:6702-6708.
9. Paczesny S., Braun T.M., Levine J.E., Hogan J., Crawford J., Coffing B., et al. Elafin is a biomarker of graft-versus-host disease of the skin. Sci Transl Med 2010, 2:13ra2.
10. Ukena S.N., Grosse J., Mischak-Weissinger E., Buchholz S., Stadler M., Ganser A., et al. Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells. Ann Hematol 2011, 90:213-218.
11. Levine J.E., Paczesny S., Sarantopoulos S. Clinical applications for biomarkers of acute and chronic graft-versus-host disease. Biol Blood Marrow Transplant 2012, 18:S116-S124.
12. Ukena S.N., Westendorf A.M., Hansen W., Rohde M., Geffers R., Coldewey S., et al. The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1. BMC Med Genet 2005, 6:43. [13].
13. Ukena S.N., Velaga S., Geffers R., Grosse J., Baron U., Buchholz S., et al. Human regulatory T cells in allogeneic stem cell transplantation. Blood 2011, 118:e82-e92.
14. Brunstein C.G., Miller J.S., Cao Q., McKenna D.H., Hippen K.L., Curtsinger J., et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011, 117:1061-1070.
15. di Ianni M., Falzetti F., Carotti A., Terenzi A., Castellino F., Bonifacio E., et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011, 117:3921-3928.
16. Edinger M., Hoffmann P., Ermann J., Drago K., Fathman C.G., Strober S., et al. CD4(+)CD25(+) regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003, 9:1144-1150.
17. Mao Y.S., Yamaga M., Zhu X., Wei Y., Sun H.Q., Wang J., et al. Essential and unique roles of PIP5K-gamma and -alpha in Fcgamma receptor-mediated phagocytosis. J Cell Biol 2009, 184:281-296.
18. Goellner B., Aberle H. The synaptic cytoskeleton in development and disease. Dev Neurobiol 2012, 72:111-125.
19. Pan F., Yu H., Dang E.V., Barbi J., Pan X., Grosso J.F., et al. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 2009, 325:1142-1146.
20. Bollyky P.L., Falk B.A., Long S.A., Preisinger A., Braun K.R., Wu R.P., et al. CD44 costimulation promotes FoxP3(+) regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta. J Immunol 2009, 183:2232-2241.
21. Liu T., Soong L., Liu G., Konig R., Chopra A.K. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4(+) T-reg cells. Biol Direct 2009, 4:40. [23].
22. Shaulian E., Karin M. AP-1 in cell proliferation and survival. Oncogene 2001, 20:2390-2400.
23. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445:771-775.
24. Lee S.M., Gao B., Fang D. FoxP3 maintains Treg unresponsiveness by selectively inhibiting the promoter DNA-binding activity of AP-1. Blood 2008, 111:3599-3606.
25. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007, 8:277-284.
26. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007, 445:936-940.
27. Takahashi N., Sato N., Takahashi S., Tojo A. Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation. Exp Hematol 2008, 36:1760-1770.